Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 29, 2021
Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
Rahul S Dalal, Scott Esckilsen, Edward L Barnes, et al.
Journal of Clinical Gastroenterology
|
December 18, 2025
Real-World Comparative Effectiveness of Vedolizumab Versus Upadacitinib for Crohn's Disease Through 52 Weeks
Rahul S Dalal, Alex Carlin, Heidy Cabral, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2019
Exposure to Intravenous Opioids Is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases
Rahul S Dalal, Sonali Palchaudhuri, Christopher K Snider, et al.
Inflammatory Bowel Diseases
|
May 23, 2020
Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases
Rahul S Dalal, Sonali Palchaudhuri, Christopher K Snider, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis
Rahul S Dalal, Mark T Osterman, Anna M Buchner, et al.
Digestive Diseases and Sciences
|
May 29, 2021
Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation: A Retrospective Cohort Study
Abraham Segura, Rahul S Dalal, Meghana Golla, et al.
The American Journal of Gastroenterology
|
September 15, 2023
Older Adult-Onset of Inflammatory Bowel Diseases Is Associated With Higher Utilization of Analgesics: A Nationwide Cohort Study
Rahul S Dalal, Bente Mertz Nørgård, Floor D Zegers, et al.
Alimentary Pharmacology & Therapeutics
|
September 8, 2025
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
Rahul S Dalal, Lindsay M Clarke, Heidy J Cabral, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
The use of opioids nine months after surgery for Crohn's disease - a nationwide cohort study
Bente Mertz Nørgård, Caroline Thingholm Thorarinsson, Floor Dijkstra Zegers, et al.
British Journal of Clinical Pharmacology
|
October 22, 2025
The persistence of chronic opioid use in patients with inflammatory bowel disease-A nationwide cohort study
Bente Mertz Nørgård, Caroline Theilgaard Thorarinsson, Jan Nielsen, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 29, 2021
Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
Rahul S Dalal, Scott Esckilsen, Edward L Barnes, et al.
Journal of Clinical Gastroenterology
|
December 18, 2025
Real-World Comparative Effectiveness of Vedolizumab Versus Upadacitinib for Crohn's Disease Through 52 Weeks
Rahul S Dalal, Alex Carlin, Heidy Cabral, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 31, 2019
Exposure to Intravenous Opioids Is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases
Rahul S Dalal, Sonali Palchaudhuri, Christopher K Snider, et al.
Inflammatory Bowel Diseases
|
May 23, 2020
Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases
Rahul S Dalal, Sonali Palchaudhuri, Christopher K Snider, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
A User-Friendly Prediction Tool to Identify Colectomy Risk in Patients With Ulcerative Colitis
Rahul S Dalal, Mark T Osterman, Anna M Buchner, et al.
Digestive Diseases and Sciences
|
May 29, 2021
Endoscopy Is Not Associated with Infectious Adverse Events After Hematopoietic Cell Transplantation: A Retrospective Cohort Study
Abraham Segura, Rahul S Dalal, Meghana Golla, et al.
The American Journal of Gastroenterology
|
September 15, 2023
Older Adult-Onset of Inflammatory Bowel Diseases Is Associated With Higher Utilization of Analgesics: A Nationwide Cohort Study
Rahul S Dalal, Bente Mertz Nørgård, Floor D Zegers, et al.
Alimentary Pharmacology & Therapeutics
|
September 8, 2025
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
Rahul S Dalal, Lindsay M Clarke, Heidy J Cabral, et al.
Alimentary Pharmacology & Therapeutics
|
May 2, 2024
The use of opioids nine months after surgery for Crohn's disease - a nationwide cohort study
Bente Mertz Nørgård, Caroline Thingholm Thorarinsson, Floor Dijkstra Zegers, et al.
British Journal of Clinical Pharmacology
|
October 22, 2025
The persistence of chronic opioid use in patients with inflammatory bowel disease-A nationwide cohort study
Bente Mertz Nørgård, Caroline Theilgaard Thorarinsson, Jan Nielsen, et al.
Page
of 5